Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Nov 4, 2016
Insider Transaction Report
Form 4
WHEELER STEVE E
Director
Transactions
- Exercise/Conversion
Stock Appreciation Right
2016-11-02−1,090→ 0 totalExercise: $12.36→ Common Stock (1,090 underlying) - Exercise/Conversion
Common Stock
2016-11-02$12.36/sh+1,090$13,472→ 34,087 total
Footnotes (1)
- [F1]Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016.